M. Ohira, Y. Imaoka, Koki Sato, Koki Imaoka, R. Nakano, N. Tanimine, H. Tahara, K. Ide, Tsuyoshi Kobayashi, Yuka Tanaka, H. Ohdan
{"title":"一项使用供体肝移植物来源的自然杀伤细胞过继免疫疗法预防肝移植后血流感染的I/II期研究:一项研究方案","authors":"M. Ohira, Y. Imaoka, Koki Sato, Koki Imaoka, R. Nakano, N. Tanimine, H. Tahara, K. Ide, Tsuyoshi Kobayashi, Yuka Tanaka, H. Ohdan","doi":"10.1186/s41231-022-00126-4","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":75244,"journal":{"name":"Translational medicine communications","volume":" ","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"A phase I/II study of adoptive immunotherapy using donor liver graft-derived natural killer cells to prevent bloodstream infection after liver transplantation: a study protocol\",\"authors\":\"M. Ohira, Y. Imaoka, Koki Sato, Koki Imaoka, R. Nakano, N. Tanimine, H. Tahara, K. Ide, Tsuyoshi Kobayashi, Yuka Tanaka, H. Ohdan\",\"doi\":\"10.1186/s41231-022-00126-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":75244,\"journal\":{\"name\":\"Translational medicine communications\",\"volume\":\" \",\"pages\":\"1-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational medicine communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s41231-022-00126-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational medicine communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41231-022-00126-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A phase I/II study of adoptive immunotherapy using donor liver graft-derived natural killer cells to prevent bloodstream infection after liver transplantation: a study protocol